Theratechnologies announces FDA approval of sBLA for F8 formulation of tesamorel
Theratechnologies (THTX) announced that the FDA has approved the Company’s supplemental Biologics License Application, or sBLA, for the F8 ...
Neurology Advisor4d
FDA Fast Tracks Investigational Nonopioid Treatment for Acute Pain
The Food and Drug Administration has granted Fast Track designation to LTG-001 for the treatment of acute pain.
Seeking Alpha1d
LMT Lockheed Martin Corporation
Lockheed Martin Corporation, an aerospace and defense company, engages in the research, design, development, manufacture, integration, and sustainment of technology systems, products, and services ...